Magyar
Toggle navigation
Tudóstér
Magyar
Tudóstér
Keresés
Egyszerű keresés
Összetett keresés
CCL keresés
Egyszerű keresés
Összetett keresés
CCL keresés
Böngészés
Saját polc tartalma
(
0
)
Korábbi keresések
Összesen 1 találat.
#/oldal:
12
36
60
120
Rövid
Hosszú
MARC
Részletezés:
Rendezés:
Szerző növekvő
Szerző csökkenő
Cím növekvő
Cím csökkenő
Dátum növekvő
Dátum csökkenő
1.
001-es BibID:
BIBFORM112650
035-os BibID:
(wos)001004057900001 (scopus)85163129757
Első szerző:
Walmsley, Martine
Cím:
Patient-reported quality of care in primary sclerosing cholangitis / Walmsley Martine, Tornai Dávid, Cazzagon Nora, Leburgue Angela, Mrzljak Anna, Lenzen Henrike, Carbone Marco, Madaleno João, Lleo Ana, Junge Norman, Schramm Christoph, Bergquist Annika
Dátum:
2023
ISSN:
1478-3223
Megjegyzések:
Background Management and follow-up strategies for primary sclerosing cholangitis (PSC) vary. The aim of the present study was to assess patient-reported quality of care to identify the most important areas for improvement. Methods Data were collected via an online survey hosted on the EU Survey platform in 11 languages between October 2021 and January 2022. Questions were asked about the disease, symptoms, treatment, investigations and quality of care. Results In total, 798 nontransplanted people with PSC from 33 countries responded. Eighty-six per cent of respondents reported having had at least one symptom. Twenty-four per cent had never undergone an elastography, and 8% had not had a colonoscopy. Nearly half (49%) had never undergone a bone density scan. Ursodeoxycholic acid (UDCA) was used in 90?93% in France, Netherlands and Germany, and 49?50% in the United Kingdom and Sweden. Itch was common (60%), and 50% of those had received any medication. Antihistamines were taken by 27%, cholestyramine by 21%, rifampicin by 13% and bezafibrate by 6.5%. Forty-one per cent had been offered participation in a clinical trial or research. The majority (91%) reported that they were confident with their care although half of the individuals reported the need for more information on disease prognosis and diet. Conclusion Symptom burden in PSC is high, and the most important areas of improvement are disease monitoring with more widespread use of elastography, bone density scan and appropriate treatment for itch. Personalised prognostic information should be offered to all individuals with PSC and include information on how they can improve their health.
Tárgyszavak:
Orvostudományok
Klinikai orvostudományok
idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
elastography
guidelines
inflammatory bowel disease
primary sclerosing cholangitis
symptoms
Megjelenés:
Liver International. - 43 : 8 (2023), p. 1654-1662. -
További szerzők:
Tornai Dávid (1989-) (hepatológia, biomarker kutatás)
Cazzagon, Nora
Leburgue, Angela
Mrzljak, Anna
Lenzen, Henrike
Carbone, Marco
Madaleno, João
Lleo, Ana
Junge, Norman
Schramm, Christoph
Bergquist, Annika
Internet cím:
Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:
Rekordok letöltése
1
Corvina könyvtári katalógus v8.2.27
© 2023
Monguz kft.
Minden jog fenntartva.